Impella saves lives in STEMI with shock, but with major risks (DanGer Shock)
What’s more dangerous than an Impella? Cardiogenic shock
Patients with acute ST-elevation myocardial infarction with cardiogenic shock treated with the Impella CP flow pump for mechanical circulatory support had increased survival at 6 months compared to those receiving standard care, the DanGer Shock randomized trial showed.
The results were a redemption of sorts for the Impella device, some models of which (…
Keep reading with a 7-day free trial
Subscribe to PulmCCM to keep reading this post and get 7 days of free access to the full post archives.